Gaush Meditech Ltd (HKG:2407)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.79
-0.53 (-8.39%)
At close: Mar 27, 2026

Gaush Meditech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
92.39173.52-349.62-190.45
Depreciation & Amortization
80.674.6964.6358.84
Other Amortization
1.341.281.121.22
Loss (Gain) From Sale of Assets
0.68-0.150.670.05
Asset Writedown & Restructuring Costs
23.26---
Loss (Gain) From Sale of Investments
-3.72-3.96-0.01-0.09
Provision & Write-off of Bad Debts
-0.56-1.24-2.244.76
Other Operating Activities
17.2333.51501.67365.18
Change in Accounts Receivable
-16.4319.688.2620.49
Change in Inventory
-5.11-48.74-41.7838.59
Change in Accounts Payable
-19.6722.1-4.18-42.57
Change in Unearned Revenue
-21.71-7.5139.8-27.6
Change in Other Net Operating Assets
-40.53-14.14-4.86-68.64
Operating Cash Flow
107.78249.04234.42164.49
Operating Cash Flow Growth
-56.72%6.24%42.52%26.53%
Capital Expenditures
-14.67-34.92-45.4-26.55
Sale of Property, Plant & Equipment
00.01--
Cash Acquisitions
-23.79-9.4-105.77
Sale (Purchase) of Intangibles
-66.55-10.67-2.62-1.5
Investment in Securities
80.19-81.11-92.7-
Other Investing Activities
43.35-31.554.682.11
Investing Cash Flow
18.55-167.65-136.0479.84
Long-Term Debt Issued
27.527.9257.7266.08
Long-Term Debt Repaid
-135.56-153.08-339.94-104.96
Net Debt Issued (Repaid)
-108.04-145.16-282.21-38.88
Issuance of Common Stock
-1.55327.829.07
Repurchase of Common Stock
-12.58---489.73
Common Dividends Paid
-148.56---
Other Financing Activities
-33.93-46.32-42.51-86.73
Financing Cash Flow
-303.09-189.943.0872.84
Foreign Exchange Rate Adjustments
-20.55.7211.07-15.66
Net Cash Flow
-197.26-102.83112.53301.51
Free Cash Flow
93.12214.11189.03137.94
Free Cash Flow Growth
-56.51%13.27%37.04%7.57%
Free Cash Flow Margin
6.52%15.23%15.08%10.63%
Free Cash Flow Per Share
0.631.451.951.44
Cash Interest Paid
33.3842.2738.8276.09
Cash Income Tax Paid
89.7185.4794.4997.43
Levered Free Cash Flow
-25.7123.94137.2-9.58
Unlevered Free Cash Flow
-2.76155.56163.8742.63
Change in Working Capital
-103.44-28.62-2.76-79.74
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.